COBAS MPX

HIV, HBV and HCV nucleic acid · class IV · Until 19/12/2026

Registration no.
10287411182
Process no.
25351517891201588
Status
Until 19/12/2026
Device type
HIV, HBV and HCV nucleic acid (ÁCIDO NUCLÉICO DE VÍRUS HIV, HBV E HCV)
Risk class
IV
Registration holder
ROCHE DIAGNÓSTICA BRASIL LTDA CNPJ 30.280.358/0001-86 · 1,784 registrations
Manufacturer
ROCHE MOLECULAR SYSTEMS, INC · United States
Published
19/12/2016
Valid until
19/12/2026
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other hiv, hbv and hcv nucleic acid registrations (13 in total, see all)

ProductClass HolderPublishedStatus
Discriminatory Probe Reagent kit (Procleix UltrioPlex E)
80134860320
IV GRIFOLS BRASIL LTDA 15/09/2025 Until 15/09/2035
Target Enhancer Reagent Kit - Procleix Ultrio Elite Assay
80134860319
IV GRIFOLS BRASIL LTDA 28/07/2025 Until 28/07/2035
Procleix Ultrio Elite Assay Calibrators
80134860317
IV GRIFOLS BRASIL LTDA 07/07/2025 Until 07/07/2035
Família Procleix UltrioPlex E Assay Calibrators
80134860314
IV GRIFOLS BRASIL LTDA 23/06/2025 Until 23/06/2035
Procleix UltrioPlex E Assay
80134860306
IV GRIFOLS BRASIL LTDA 19/02/2024 Until 19/02/2034
Kit NAT PLUS HIV/HBV/HCV/Malária Bio-Manguinhos
80142170056
IV FUNDACAO OSWALDO CRUZ 21/03/2022 Until 21/03/2032
Cobas HBV/HCV/HIV-1 Control Kit
10287411180
IV ROCHE DIAGNÓSTICA BRASIL LTDA 19/12/2016 Until 19/12/2036
Cobas HBV/HCV/HIV-1 Control Kit 4800
10287411161
IV ROCHE DIAGNÓSTICA BRASIL LTDA 05/09/2016 Until 05/09/2036